| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0031 | 1 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.0078 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.0067 | 1 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |